Tau protein and the neurofibrillary pathology of Alzheimer's disease
- PMID: 7507619
- DOI: 10.1016/0166-2236(93)90078-z
Tau protein and the neurofibrillary pathology of Alzheimer's disease
Abstract
Abundant neurofibrillary tangles, neuropil threads and senile plaque neurites constitute the neurofibrillary pathology of Alzheimer's disease. They form in the nerve cells that undergo degeneration in the disease, in which their regional distribution correlates with the degree of dementia. Each lesion contains the paired helical filament (PHF) as its major fibrous component. Recent work has shown that PHFs are composed of the microtubule-associated protein tau in an abnormally phosphorylated state. PHF-tau is hyperphosphorylated on all six adult brain isoforms. As a consequence, tau is unable to bind to microtubules and is believed to self-assemble into the PHF. Current evidence suggests that protein kinases or protein phosphatases with a specificity for serine/threonine-proline residues are involved in the abnormal phosphorylation of tau.
Similar articles
-
Tau protein and the neurofibrillary pathology of Alzheimer's disease.Ann N Y Acad Sci. 1996 Jan 17;777:121-31. doi: 10.1111/j.1749-6632.1996.tb34410.x. Ann N Y Acad Sci. 1996. PMID: 8624074 Review.
-
Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.Arzneimittelforschung. 1995 Mar;45(3A):403-9. Arzneimittelforschung. 1995. PMID: 7763334 Review.
-
Molecular dissection of the paired helical filament.Neurobiol Aging. 1995 May-Jun;16(3):325-34. doi: 10.1016/0197-4580(95)00017-9. Neurobiol Aging. 1995. PMID: 7566342 Review.
-
Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.J Neural Transm Suppl. 1998;53:169-80. doi: 10.1007/978-3-7091-6467-9_15. J Neural Transm Suppl. 1998. PMID: 9700655 Review.
-
Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles.Acta Neuropathol. 1996 Jul;92(1):42-8. doi: 10.1007/s004010050487. Acta Neuropathol. 1996. PMID: 8811124
Cited by
-
Guidelines for the use and interpretation of Alzheimer's disease biomarkers in clinical practice in Brazil: recommendations from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology.Dement Neuropsychol. 2024 Nov 11;18:e2024C001. doi: 10.1590/1980-5764-DN-2024-C001. eCollection 2024. Dement Neuropsychol. 2024. PMID: 39534442 Free PMC article.
-
Amyloid-Beta, Tau, and Microglial Activation in Aged Felid Brains.J Comp Neurol. 2024 Nov;532(11):e25679. doi: 10.1002/cne.25679. J Comp Neurol. 2024. PMID: 39474737
-
Understanding Osaka mutation polymorphic Aβ fibril response to static and oscillating electric fields: insights from computational modeling.Sci Rep. 2024 Sep 27;14(1):22246. doi: 10.1038/s41598-024-72778-1. Sci Rep. 2024. PMID: 39333193 Free PMC article.
-
Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.Signal Transduct Target Ther. 2024 Aug 23;9(1):211. doi: 10.1038/s41392-024-01911-3. Signal Transduct Target Ther. 2024. PMID: 39174535 Free PMC article. Review.
-
Role of Tau Protein in Neurodegenerative Diseases and Development of Its Targeted Drugs: A Literature Review.Molecules. 2024 Jun 13;29(12):2812. doi: 10.3390/molecules29122812. Molecules. 2024. PMID: 38930877 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
